Star Combo Pharma Limited received a $5.0M order, its large OEM order to date from a leading Australian health supplement brand for the manufacturing of approximately 290 million bulk capsules to be completed by the end of third quarter of 2022 financial year, a positive start to the second quarter of 2022 financial year. Star Combo's manufacturing relationship with this supplement brand has been strengthening over the last 12 months and Star Combo anticipates further orders in the future following the brand's review of its long-term strategy. The supplement brand is now seeking manufacturing capabilities not previously required.